Top Medical News

Low-Dose Rituximab Safe, as Effective as High Dose in MS

September 24, 2020

By Marco Meglio

In the third year of treatment, both dose cohorts did not experience any contrast-enhancing lesions, and only a small population in the Barcelona center showed new T2 lesions.

Midazolam for Status Epilepticus Underutilized in EMS Setting Despite High Efficacy

September 24, 2020

By Marco Meglio

Notably, no patients received a dose and route consistent with national guidelines.

Ocrelizumab Shows Range of Benefits for Spectrum of Patients With Multiple Sclerosis

September 24, 2020

By Matt Hoffman

The medical director manager of neuroscience at Genentech discussed the swath of data presented on the humanized anti-CD20 monoclonal antibody at MS Virtual.

Early Intensive MS Treatment Yields Better Outcomes Than Escalation Approach

September 23, 2020

By Matt Hoffman

Early intensive treatment was more effective in controlling disability progression over time compared with an escalation therapy approach.

Fatigue Plays a Key Factor in Multiple Sclerosis Daily Functioning

September 23, 2020

By Marco Meglio

Patients with lower levels of disability tended to report fatigue as the most impactful symptom in daily life.

Featured


Latest Videos


Most Recent

New content coming soon, please check back later.